PHARMA SA
Location
Iasi
Founded
2000-12-06
Website
Risk Signals
21 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Drugs, Drug Proprietaries, and Druggists' Sundries, Groceries and Related Products, Not Elsewhere Classified, Chemicals and Allied Products, Not Elsewhere Classified, Petroleum and Petroleum Products Wholesalers, Except Bulk Stations and Terminals, Nondurable Goods, Not Elsewhere Classified, Motor Vehicle Dealers (New and Used)), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about PHARMA SA
Live alerts from global media, monitored by Business Radar
2024-06-17 (businesswire.com)
Innate Pharma Shares Updated Results From the Sanofi Developed Blood Cancer Phase 1/2 SAR443579/IPH6101 Trial
Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) announced today that updated efficacy and safety res
Read more
2022-12-15 (business-review.eu)
Biofarm increases production of paracetamol-based syrups for children - Business Review
Pharma - Biofarm, one of the most important drug manufacturers in Romania, announces increased production of paracetamol-based medicines for the treatment of fever
Read more
(businesswire.com)
Innate Pharma Announces First Patient Dosed in Phase 1 Study of Its Nectin-4 Targeting Antibody Drug Conjugate IPH4502 in Selected Advanced Solid Tumors
Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced the first patient was dosed in its Phase 1 ...
Read more